• OPEN AN ACCOUNT
Indian Indices
Sensex
77,611.37 -43.23
( -0.06%)
Global Indices
Nasdaq
51,626.09 -1,142.23
(-2.16%)
Dow Jones
7,338.46 -111.32
(-1.49%)
Hang Seng
61,899.63 465.44
(0.76%)
Nikkei 225
10,896.96 25.94
(0.24%)
Forex
USD-INR
95.71 -0.26
(-0.27%)
EUR-INR
108.89 -0.40
(-0.37%)
GBP-INR
127.22 -0.62
(-0.49%)
JPY-INR
0.58 0.00
(-0.38%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
34.29
847.27
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.07
 

P I Industries consolidated net profit declines 39.43% in the March 2026 quarter
May 20,2026
Net profit of P I Industries declined 39.43% to Rs 200.20 crore in the quarter ended March 2026 as against Rs 330.50 crore during the previous quarter ended March 2025. Sales declined 12.42% to Rs 1565.20 crore in the quarter ended March 2026 as against Rs 1787.10 crore during the previous quarter ended March 2025.

For the full year,net profit declined 20.44% to Rs 1320.80 crore in the year ended March 2026 as against Rs 1660.20 crore during the previous year ended March 2025. Sales declined 15.85% to Rs 6713.70 crore in the year ended March 2026 as against Rs 7977.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1565.201787.10 -12 6713.707977.80 -16
OPM %21.5225.49 -25.3227.31 -
PBDT409.20522.40 -22 1999.602494.50 -20
PBT302.50432.20 -30 1593.002142.00 -26
NP200.20330.50 -39 1320.801660.20 -20